Paroxysmal nocturnal hemoglobinuria (PNH) happens when your immune system attacks your red blood cells and platelets. If not treated, it can lead to complications that include blood clots, anemia, and ...
Dr Haumschild continues leading an expert discussion surrounding key strategies and pain points in PNH treatment. Please describe the significance of the different efficacy end points explored for ...
"We need longer follow-up with the newer complement inhibitors to be sure that they’re safe long-term and that there won’t be excessive intravascular breakthrough hemolysis/thrombosis. Some of these ...
AJMC ®: Paroxysmal nocturnal hemoglobinuria (PNH) is 1 of several complement-driven diseases. Can you describe its clinical presentation? DE CASTRO: PNH presents heterogeneously. One of the 3 ...
Atropos Health is integrating the American Society of Clinical Oncology (R) (ASCO (R)) Guidelines into their platform and presenting rare disease AI algorithms at the 67th American Society of ...
In this interview, we spoke with Gloria Gerber, MD, a hematologist and assistant professor of medicine at Johns Hopkins University, about the evolution of treatment for paroxysmal nocturnal ...
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare immune disease that causes your body to break down red blood cells when it should not. This disorder happens when there is a problem with certain ...
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, potentially life-threatening disorder linked to a specific gene. It can occur at any age but most often is diagnosed in young adults. PNH ...
Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback